Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMMX Immix Biopharma, Inc

交易中 07-28 15:39:15 EDT

2.71

+0.00

0.00%

最高2.89	最低2.68	成交量20.19万
今开2.76	昨收2.71	日振幅7.75%
总市值7,548万	流通市值4,895万	总股本2,785万
成交额55.87万	换手率1.12%	流通股本1,806万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMMX","market":"US","secType":"STK","nameCN":"Immix Biopharma, Inc","latestPrice":2.71,"timestamp":1753731372305,"preClose":2.71,"halted":0,"volume":201901,"delay":0,"floatShares":18062555,"shares":27852341,"eps":-0.700031,"marketStatus":"交易中","change":0,"latestTime":"07-28 15:39:15 EDT","open":2.76,"high":2.89,"low":2.68,"amount":558736.0625363999,"amplitude":0.077491,"askPrice":2.71,"askSize":100,"bidPrice":2.68,"bidSize":2470,"shortable":3,"etf":0,"ttmEps":-0.700031,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1753732800000},"marketStatusCode":2,"adr":0,"listingDate":1639630800000,"exchange":"NASDAQ","adjPreClose":2.71,"preHourTrading":{"tag":"盘前","latestPrice":2.71,"preClose":2.71,"latestTime":"08:00 EDT","volume":29,"amount":78.59,"timestamp":1753704000272},"postHourTrading":{"tag":"盘后","latestPrice":2.71,"preClose":2.71,"latestTime":"16:11 EDT","volume":2,"amount":5.42,"timestamp":1753474319099},"volumeRatio":0.966581,"impliedVol":1.9723,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/IMMX","defaultTab":"news","newsList":[{"id":"2554177740","title":"Immix Biopharma, Inc.盘中异动 早盘急速拉升5.41%报2.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554177740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554177740?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:05","pubTimestamp":1753711545,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时05分，Immix Biopharma, Inc.股票出现异动，股价急速上涨5.41%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Celcuity Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Cervomed Inc.涨幅较大，Tnf Pharmaceuticals, Inc.、Cervomed Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为142.69%、104.36%、61.76%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Celcuity Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 ，振幅分别为45.09%、37.76%、36.48%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822054594bf7be3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822054594bf7be3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2552143382","title":"Immix Biopharma, Inc.盘中异动 股价大涨5.08%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552143382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552143382?lang=zh_cn&edition=full","pubTime":"2025-07-18 00:21","pubTimestamp":1752769299,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日00时21分，Immix Biopharma, Inc.股票出现波动，股价急速拉升5.08%。截至发稿，该股报3.10美元/股，成交量16.9142万股，换手率0.61%，振幅6.25%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071800213997a9fcc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071800213997a9fcc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2551912523","title":"Immix Biopharma, Inc.盘中异动 早盘大幅上涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551912523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551912523?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:34","pubTimestamp":1752672874,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时34分，Immix Biopharma, Inc.股票出现波动，股价急速上涨5.43%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Qualigen Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026涨幅较大，Qualigen Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为1603.34%、885.29%、384.43%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Windtree Therapeutics, Inc.，振幅分别为34.27%、23.35%、20.52%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213435a6ada1f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213435a6ada1f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2551339211","title":"Immix Biopharma, Inc.盘中异动 急速拉升5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551339211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551339211?lang=zh_cn&edition=full","pubTime":"2025-07-15 02:31","pubTimestamp":1752517860,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日02时31分，Immix Biopharma, Inc.股票出现波动，股价大幅上涨5.64%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Biodexa Pharmaceuticals Plc涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为2103.48%、1339.29%、747.75%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.，振幅分别为217.02%、216.70%、210.04%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715023100a6a95059&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715023100a6a95059&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2548807026","title":"Immix Biopharma, Inc.盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548807026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548807026?lang=zh_cn&edition=full","pubTime":"2025-07-03 21:41","pubTimestamp":1751550106,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日21时41分，Immix Biopharma, Inc.股票出现波动，股价快速拉升5.25%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Lixte Biotechnology Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Theratechnologies Inc.涨幅较大，Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为1748.91%、805.83%、618.65%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Lixte Biotechnology Holdings, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为54.55%、38.11%、36.41%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703214146a4cd809f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703214146a4cd809f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2547090982","title":"Immix Biopharma, Inc.盘中异动 股价大跌5.53%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547090982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547090982?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:59","pubTimestamp":1751291955,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时59分，Immix Biopharma, Inc.股票出现波动，股价急速下挫5.53%。截至发稿，该股报2.05美元/股，成交量3.4925万股，换手率0.13%，振幅4.84%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021591695315833&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021591695315833&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2546419723","title":"Immix Biopharma, Inc.盘中异动 股价大跌6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546419723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546419723?lang=zh_cn&edition=full","pubTime":"2025-06-28 01:38","pubTimestamp":1751045912,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日01时38分，Immix Biopharma, Inc.股票出现波动，股价大幅下挫6.25%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Eyenovia, Inc.、天境生物、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Inmune Bio Inc.、Hcw Biologics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为220.94%、163.25%、122.73%，振幅较大的相关个股有Inmune Bio Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Channel Therapeutics Corporation，振幅分别为103.03%、74.75%、64.91%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628013832a4c1ac4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628013832a4c1ac4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2545417735","title":"Immix Biopharma, Inc.盘中异动 股价大涨7.59%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545417735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545417735?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:41","pubTimestamp":1750686112,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时41分，Immix Biopharma, Inc.股票出现异动，股价急速拉升7.59%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Impact Biomedical, Inc.、Cidara Therapeutics, Inc.、Indaptus Therapeutics, Inc.涨幅较大，Indaptus Therapeutics, Inc.、Impact Biomedical, Inc.、Nucana Plc较为活跃，换手率分别为1036.21%、1008.96%、232.89%，振幅较大的相关个股有Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为71.80%、64.31%、61.93%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623214152952818a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623214152952818a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2545170943","title":"Immix Biopharma, Inc.盘中异动 快速下跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545170943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545170943?lang=zh_cn&edition=full","pubTime":"2025-06-21 03:55","pubTimestamp":1750449331,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日03时55分，Immix Biopharma, Inc.股票出现波动，股价急速下挫5.44%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Cingulate Inc C/Wts 10/12/2026 、Processa Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Processa Pharmaceuticals, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为1884.09%、1218.11%、462.13%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为84.05%、65.00%、63.48%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062103553295251d1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062103553295251d1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2544783997","title":"Immix Biopharma, Inc.盘中异动 大幅跳水5.00%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544783997","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544783997?lang=zh_cn&edition=full","pubTime":"2025-06-18 03:05","pubTimestamp":1750187124,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日03时05分，Immix Biopharma, Inc.股票出现异动，股价大幅跳水5.00%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.51%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.、Acurx Pharmaceuticals, Inc.涨幅较大，Cero Therapeutics Holdings, Inc.、Processa Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为10562.56%、4743.88%、2425.92%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Processa Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.，振幅分别为450.48%、260.06%、242.28%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618030525a4aeebde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618030525a4aeebde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2542933899","title":"Immix Biopharma, Inc.盘中异动 快速上涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542933899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542933899?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:36","pubTimestamp":1749476191,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时36分，Immix Biopharma, Inc.股票出现异动，股价急速上涨5.49%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Synaptogenix, Inc.涨幅较大，Pmgc Holdings Inc.、Klotho Neurosciences, Inc.、Synaptogenix, Inc.较为活跃，换手率分别为1108.59%、992.93%、677.89%，振幅较大的相关个股有Tenaya Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Turnstone Biologics Corp.，振幅分别为117.86%、98.84%、97.01%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092136319514d577&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092136319514d577&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2540179194","title":"Immix Biopharma, Inc.盘中异动 早盘急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540179194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540179194?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:29","pubTimestamp":1748874584,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日22时29分，Immix Biopharma, Inc.股票出现波动，股价急速拉升5.12%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Lyra Therapeutics, Inc.、Oragenics Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1385.52%、986.06%、323.25%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为248.28%、87.92%、80.43%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602222944a6f73233&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602222944a6f73233&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2539261161","title":"Immix Biopharma, Inc.盘中异动 早盘快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539261161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539261161?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:48","pubTimestamp":1748530094,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日22时48分，Immix Biopharma, Inc.股票出现异动，股价大幅拉升5.13%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Alzamend Neuro, Inc.、Oric Pharmaceuticals, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026涨幅较大，Alzamend Neuro, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为7751.83%、527.08%、373.17%，振幅较大的相关个股有Alzamend Neuro, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为61.45%、52.38%、50.55%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052922481495070dc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052922481495070dc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2537978132","title":"Immix Biopharma, Inc.股价重挫13.28% 市值跌773.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537978132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537978132?lang=zh_cn&edition=full","pubTime":"2025-05-23 21:31","pubTimestamp":1748007107,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日21时31分，Immix Biopharma, Inc.股票出现波动，股价快速下跌13.28%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Imunon, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Imunon, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为1085.89%、1071.55%、337.43%，振幅较大的相关个股有Imunon, Inc.、Celularity Inc.、Fulcrum Therapeutics, Inc.，振幅分别为24.07%、10.44%、9.80%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213147a489c504&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213147a489c504&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2537944053","title":"Immix Biopharma, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537944053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537944053?lang=zh_cn&edition=full","pubTime":"2025-05-22 21:51","pubTimestamp":1747921899,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日21时51分，Immix Biopharma, Inc.股票出现波动，股价快速上涨5.26%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Vigil Neuroscience, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Polyrizon Ltd.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃，换手率分别为1688.29%、1669.41%、557.26%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Protagenic Therapeutics Inc C/Wts 26/04/2026 ，振幅分别为43.48%、39.19%、34.53%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052221513994ff43b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052221513994ff43b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2535982233","title":"Immix Biopharma, Inc.盘中异动 早盘股价大涨5.05%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535982233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535982233?lang=zh_cn&edition=full","pubTime":"2025-05-15 22:34","pubTimestamp":1747319683,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日22时34分，Immix Biopharma, Inc.股票出现异动，股价快速拉升5.05%。截至发稿，该股报2.08美元/股，成交量2061股，换手率0.01%，振幅4.55%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。其候选产品包括治疗自身免疫性疾病的 CAR-T NXC-201 和治疗软组织肉瘤的 IMX-110。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515223443aa2c900e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515223443aa2c900e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2533465743","title":"Immix Biopharma, Inc.盘中异动 股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533465743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533465743?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:54","pubTimestamp":1746550451,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时54分，Immix Biopharma, Inc.股票出现异动，股价快速下跌5.42%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为5.69%。其相关个股中，Liminatus Pharma Inc C/Wts 30/04/2030 、Sol-Gel Technologies Ltd.、Tiziana Life Sciences Ltd涨幅较大，Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃，换手率分别为7950.88%、1202.02%、504.68%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Celularity Inc C/Wts 16/07/2026 、Protagenic Therapeutics, Inc.，振幅分别为158.45%、69.05%、47.02%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507005411aa2c84d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507005411aa2c84d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2533380415","title":"Immix Biopharma, Inc.盘中异动 早盘快速跳水5.49%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533380415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533380415?lang=zh_cn&edition=full","pubTime":"2025-05-05 22:10","pubTimestamp":1746454223,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日22时10分，Immix Biopharma, Inc.股票出现异动，股价急速下跌5.49%。截至发稿，该股报1.98美元/股，成交量1.1789万股，换手率0.04%，振幅7.52%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。其候选产品包括治疗自身免疫性疾病的 CAR-T NXC-201 和治疗软组织肉瘤的 IMX-110。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505221023aa2c8311&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505221023aa2c8311&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2532442118","title":"Immix Biopharma, Inc.盘中异动 早盘股价大涨5.64%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532442118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532442118?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:30","pubTimestamp":1746192628,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时30分，Immix Biopharma, Inc.股票出现异动，股价急速拉升5.64%。截至发稿，该股报2.16美元/股，成交量1038股，换手率0.00%，振幅5.88%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050221302994eac20d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050221302994eac20d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2532683006","title":"Immix Biopharma, Inc.盘中异动 急速上涨5.26%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532683006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532683006?lang=zh_cn&edition=full","pubTime":"2025-05-01 22:23","pubTimestamp":1746109413,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日22时23分，Immix Biopharma, Inc.股票出现异动，股价急速拉升5.26%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Transcode Therapeutics, Inc.、Relmada Therapeutics, Inc.、Lexeo Therapeutics, Inc.涨幅较大，Transcode Therapeutics, Inc.、Processa Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为172.76%、42.45%、22.33%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为36.89%、24.75%、21.74%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501222333aa2c80ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501222333aa2c80ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immixbio.com","stockEarnings":[{"period":"1week","weight":-0.0875},{"period":"1month","weight":0.2235},{"period":"3month","weight":0.4492},{"period":"6month","weight":0.322},{"period":"1year","weight":0.2605},{"period":"ytd","weight":0.2318}],"compareEarnings":[{"period":"1week","weight":0.0152},{"period":"1month","weight":0.0494},{"period":"3month","weight":0.157},{"period":"6month","weight":0.0479},{"period":"1year","weight":0.1833},{"period":"ytd","weight":0.0871}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immix Biopharma, Inc.于2014年1月7日成立为特拉华州公司。公司是一家临床阶段的生物制药公司，专注于嵌合抗原受体细胞疗法（“CAR-T”）在轻链（AL）淀粉样变性和自身免疫性疾病中的应用。公司主导细胞治疗候选药物为美国食品药品监督管理局（“FDA”）研究性新药（“IND”）批准的CAR-T NXC-201，目前正在公司进行的1b/2a期NEXICART-1（NCT04720313）临床试验中进行评估。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.072585},{"month":2,"riseRate":0,"avgChangeRate":-0.16788},{"month":3,"riseRate":0,"avgChangeRate":-0.114009},{"month":4,"riseRate":0.5,"avgChangeRate":-0.026863},{"month":5,"riseRate":0.5,"avgChangeRate":0.112474},{"month":6,"riseRate":0.5,"avgChangeRate":0.09241},{"month":7,"riseRate":0.5,"avgChangeRate":0.014724},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.078281},{"month":9,"riseRate":0.333333,"avgChangeRate":0.042748},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.044134},{"month":11,"riseRate":1,"avgChangeRate":0.313451},{"month":12,"riseRate":1,"avgChangeRate":0.429808}],"exchange":"NASDAQ","name":"Immix Biopharma, Inc","nameEN":"Immix Biopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immix Biopharma, Inc(IMMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immix Biopharma, Inc,IMMX,Immix Biopharma, Inc股票,Immix Biopharma, Inc股票老虎,Immix Biopharma, Inc股票老虎国际,Immix Biopharma, Inc行情,Immix Biopharma, Inc股票行情,Immix Biopharma, Inc股价,Immix Biopharma, Inc股市,Immix Biopharma, Inc股票价格,Immix Biopharma, Inc股票交易,Immix Biopharma, Inc股票购买,Immix Biopharma, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immix Biopharma, Inc(IMMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况